Skip to content
Medxy AI
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • HRR mutations
Posted inClinical Updates

PARP inhibitors shine: How the TALAPRO-2 trial is changing the landscape of prostate cancer with precision medicine

Posted by By Dr.Paul 08/07/2025
Treatment for advanced prostate cancer has advanced significantly in the past decade, but metastatic castration-resistant…
Read More
  • Personalizing Oxaliplatin Dosing: Reducing Neurotoxicity in Stage III Colon Cancer—Insights from the LEANOX Trial
  • Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: Insights from the SURF-RCT and SURF-Cohort Trials
  • Consecutive Fecal Microbiota Transplantation in MASLD: Insights from a Double-Blind Randomized Controlled Trial
  • Ruxolitinib Offers Durable Clinical Benefit in Steroid-Refractory Chronic Graft-Versus-Host Disease: Three-Year Final Results of the REACH3 Trial
  • Global Insights into Childhood Bronchiectasis: The First Multinational Registry Study Reveals Striking Variations and Care Gaps
  • About us
  • Contact us
  • Privacy Policy
  • Subscribe Now!
  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease Antibiotics blood pressure breast cancer cancer cardiovascular health cardiovascular risk clinical trial clinical trials colorectal cancer COPD Dementia diabetes diet dinh dưỡng epidemiology exercise FDA FDA approval health healthcare Healthy Eating HIV Hypertension immunotherapy longevity MASLD men's health mental health nutrition obesity Pregnancy prevention public health randomized trial semaglutide sexual health sleep treatment Vaccine weight loss wellness women's health 健康

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top